According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

(Image Credits: Pixabay) Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective and disease-modifying therapies (DMTs). With current ...

Engineered polymers interfere with protein interactions to protect cell health in a mouse study. Researchers at Northwestern University and Case Western Reserve University have developed the first ...

Experts made the discovery after analysing hours of YouTube footage of celebrities with the disease - and it paves the way ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

The research team suggests that the treatment can help address very early stages of a condition such as Alzheimer’s or ...

Global Central Nervous System Therapeutics Market is valued at approximately USD 143.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period ...

Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not diagnosed until ...

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

Favorable capital market conditions last week enabled the company to raise over $15 million from secondary offerings, and the proceeds allow the Company to fund fully the costs of this upcoming ...